JAK1 Inhibitors for Eczematous Eruptions Following Anti-IL-17A Therapy in Psoriasis: A Case Series
Psoriasis: Targets and Therapy · 2026-10 · Volume 16 · 1-7
DOI: 10.2147/ptt.s640212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psoriasis: Targets and Therapy, 2026-10. Verfasst von Li Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
- Ruijin-Yatsen Joint Laboratory, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
ORCID-Profile: Li Zhang
Zitieren
APA
Zhang, L., Wu, J., Zheng, J., Chen, L., Wang, Y., & Li, X. (2026). JAK1 Inhibitors for Eczematous Eruptions Following Anti-IL-17A Therapy in Psoriasis: A Case Series. Psoriasis: Targets and Therapy, Volume 16, 1-7. https://doi.org/10.2147/ptt.s640212
Vancouver
Zhang L, Wu J, Zheng J, Chen L, Wang Y, Li X. JAK1 Inhibitors for Eczematous Eruptions Following Anti-IL-17A Therapy in Psoriasis: A Case Series. Psoriasis: Targets and Therapy. 2026;Volume 16:1-7. doi:10.2147/ptt.s640212
BibTeX
@article{Zhang2026,
author = {Zhang, Li and Wu, Jingwen and Zheng, Jie and Chen, Lihong and Wang, Youcong and Li, Xia},
title = {JAK1 Inhibitors for Eczematous Eruptions Following Anti-IL-17A Therapy in Psoriasis: A Case Series},
journal = {Psoriasis: Targets and Therapy},
year = {2026},
volume = {Volume 16},
pages = {1--7},
doi = {10.2147/ptt.s640212}
}
EUVIMED